About Neurosynaptic
Neurosynaptic is a Healthcare company based in Bengaluru (India) founded in 2002 by Rajeev Kumar and Sameer Subhash Sawarkar. ICT-based products and solutions are developed for healthcare. Neurosynaptic has raised $1.61 million across 6 funding rounds from investors including KOIS, HealthQuad and Axilor Ventures. The company has 30 employees. Neurosynaptic was last valued at $3.73 million in September 2020. Its chief executive, as recorded, is Sameer Subhash Sawarkar. Its Indian entity Neurosynaptic Communications Private Limited reported revenue of ₹9.78 Cr. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations.
Company details
Neurosynaptic is a healthcare technology involved in the development of ICT-based products. The company developing a diagnostic kit - ReMeDi for medical data storage and access and comprising of products such as ECG, stethoscope, temperature measuring, oximeter, etc. The professional edition provides patient and doctor application software which is cloud-based and enables remote consultation. Its enterprise edition comprises of server application along with patient and doctor-client applications offering multiple features. The company claims that its flagship platform, ReMeDi has been deployed in 1600 operational health centers in several developing countries and reaches 50 million people.
- Headquarters Bengaluru, India
- Employees 30
- Founders Rajeev Kumar, Sameer Subhash Sawarkar
- Stage Minicorn
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website neurosynaptic.com
- Social LinkedIn X Facebook YouTube
- Legal Name Neurosynaptic Communications Private Limited
- Date of Incorporation 20 Sep, 2002
- Jurisdiction Bangalore, Karnataka, India
- Annual Revenue₹9.78 Cr
FY 2025 · -11% YoY
- Net Profit₹37.2 Lakh
FY 2025 · 4% margin
- EBITDA₹1.98 Cr
FY 2025 · 20% margin
- Total Equity Funding$1.61M (USD)
in 6 rounds
- Latest Funding Round$118.8K (USD), Series A
Sep 2020
- InvestorsKOIS
& 58 more
- Employee Count30
Associated legal entities of Neurosynaptic
Neurosynaptic operates through Neurosynaptic Communications Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Neurosynaptic Communications Private Limited CIN U73100KA2002PTC031023 | Active | 20 Sep 2002 | Bangalore, Karnataka | ₹9.8 Cr | 30 | 5 | View details |
Apps and channels of Neurosynaptic
its YouTube channel NeurosynapticCommn has 12 subscribers.
Funding Insights of Neurosynaptic
Neurosynaptic has successfully raised a total of $1.61M across 6 strategic funding rounds. The most recent funding activity was a Series A round of $118.8 thousand completed in September 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.61M
- Total Rounds 6
- Last Round Series A — $118,795
- First Round $392,536
(Jul 2006)
- Investors Count 59
All 6 funding rounds of Neurosynaptic with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2020 | $118,795 | Series A | $3.73M | KOIS | |
| May 2019 | $54,202 | Series A | $3.48M | Nagaraja Prakasam, Sunil Kant Munjal | |
| Sep 2016 | $951,046 | Series A | $••••• | HealthQuad | |
| Dec 2013 | $93,320 | Seed | $••••• | e-Zest | – |
| Jun 2012 | Grant | – | – | ||
| Jul 2006 | $392,536 | Seed | $••••• | Ventureast |
| Date | Valuation | Stage |
|---|---|---|
| Sep 2020 | $3.73M | •••••••• |
| May 2019 | $3.48M | •••••••• |
| Sep 2016 | $••••• | •••••••• |
| Jul 2006 | $••••• | •••••••• |
Full valuation and stage history of Neurosynaptic
Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.
- All valuation points
- Stage changes
- Dates
- Exports
Verified entity values are shown only after access is granted.
Last known valuation $3.73M (Sep 2020). 59 investors in total: 20 institutional and 39 angel.
Investors in Neurosynaptic
Neurosynaptic has secured backing from 59 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include KOIS, HealthQuad and Axilor Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity firm focused on acquisitions | 2010 | koisinvest.com | Brussels, Belgium | |
Healthcare investment fund focused on innovation and social impact in India. | 2016 | healthquad.in | Delhi, India | |
Angel investor network investing in early-stage startups | iangroup.vc | Delhi, India | ||
Venture capital firm investing in early-stage startups in technology sectors. | 2014 | axilor.com | Bengaluru, India | |
Venture capital funding and support for healthtech startups. | 2015 | curraehealthtech.com | Mumbai, India | |
Private investment arm of Kris Gopalakrishnan Family Office. | 2014 | pratithi.com | Bengaluru, India | |
Logistics tech and multiple sectors are funded by VAPP Ventures. | Kolkata, India | |||
Venture capital investments in technology, healthcare, and clean environment sectors since 1997. | 1997 | ventureast.net | Bengaluru, India | |
IT suite and digital transformation services are provided globally. | 2000 | e-zest.com | Chicago, United States | |
Real estate investments are managed for risk-adjusted returns by Pragnya. | pragnyafunds.com | Port Louis, Mauritius |
Investor details for Neurosynaptic
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Neurosynaptic Communications Private Limited (Neurosynaptic)
Neurosynaptic Communications Private Limited is the primary company behind Neurosynaptic. The board of Neurosynaptic Communications Private Limited currently have 5 directors; the longest-serving is Sameer Subhash Sawarkar, appointed in 2002. 7 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sameer Subhash Sawarkar DIN 01745713 | Whole-time director | 20 Sep 2002 | 24 yrs 1 mo | Neurosynaptic Communications Private Limited |
| Rajeev Kumar DIN 01745694 | Whole-time director | 26 Dec 2003 | 22 yrs 10 mo | Neurosynaptic Communications Private Limited |
| Nagaraja Prakasam DIN 01801524 | Nominee Director | 25 Apr 2016 | 10 yrs 6 mo | Neurosynaptic Communications Private Limited |
| Charles Antoine Janssen DIN 01266976 | Nominee Director | 08 Oct 2021 | 5 yrs | Neurosynaptic Communications Private Limited |
| Shrikant Vasudevrao Shingane DIN 02181954 | Director | 24 Mar 2023 | 3 yrs 7 mo | Neurosynaptic Communications Private Limited |
People of Neurosynaptic
2 people are tracked at Neurosynaptic (2 in leadership); the tracked headcount is 30.
| Name | Role | Group |
|---|---|---|
| Co-Founder & COO | Leadership | |
| Co-Founder & CEO | Leadership |
Complete people profiles for Neurosynaptic
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Neurosynaptic
Figures of Neurosynaptic Communications Private Limited, the primary company behind Neurosynaptic, for FY 2025. Revenue was ₹9.78 Cr (-11% year on year). Net profit was ₹37.2 Lakh (4% margin). EBITDA was ₹1.98 Cr (20% margin). Revenue has grown at a compounded annual rate of +8% over three years and +37% over five years.
- ₹9.78 CrRevenue · FY 2025 · -11% YoY
- ₹37.2 LakhNet profit · 4% margin
- ₹1.98 CrEBITDA · 20% margin
- ₹66.7 LakhPaid-up capital
- 30Employees (provident fund records)
- +8%Revenue CAGR, 3 years
- +37%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Neurosynaptic Communications Private Limited are on its company page.
Detailed financial statements for Neurosynaptic
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Neurosynaptic
4 dated milestones of Neurosynaptic across 18 years, from founding to its latest funding, stage changes and deals.
- Founded Neurosynaptic is founded.
- Funding First funding round of $393K.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Series A, of $119K.
Web traffic of Neurosynaptic
The website of Neurosynaptic (neurosynaptic.com) receives about 1.1K visits a month.
- Monthly visits1.1K
▲ 25.7% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Neurosynaptic
Complete news archive for Neurosynaptic
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Neurosynaptic
Neurosynaptic was founded in 2002 and raised its 1st funding round 4 years after it was founded.
Neurosynaptic is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Sameer Subhash Sawarkar is the CEO of Neurosynaptic, as recorded in our data. They have also founded this company.
Neurosynaptic is a funded company, having raised a total of $1.61M across 6 funding rounds to date. The company's 1st funding round was a Seed of $392.54K, raised on Jul 2006.
Neurosynaptic has 30 employees.
The primary company behind Neurosynaptic, Neurosynaptic Communications Private Limited, reported revenue of ₹9.78 Cr for FY 2025, down 11% year on year.
Neurosynaptic is a healthcare technology involved in the development of ICT-based products. The company developing a diagnostic kit - ReMeDi for medical data storage and access and comprising of products such as ECG, stethoscope, temperature measuring, oximeter, etc. The professional edition provides patient and doctor application software which is cloud-based and enables remote consultation. Its enterprise edition comprises of server application along with patient and doctor-client applications offering multiple features. The company claims that its flagship platform, ReMeDi has been deployed in 1600 operational health centers in several developing countries and reaches 50 million people.
Neurosynaptic has 59 investors. Key investors include KOIS, HealthQuad, Axilor Ventures, Ventureast, and e-Zest.
The valuation of Neurosynaptic is $3.73M as of Sep 2020.
Neurosynaptic operates through Neurosynaptic Communications Private Limited.
The legal entities of Neurosynaptic currently have 5 directors, including Shrikant Vasudevrao Shingane, Charles Antoine Janssen, Nagaraja Prakasam and others.